Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D in Primary Restless Legs Syndrome
NCT02256215Phase 3Unknown
- Sponsor
- King Abdulaziz University
- Start
- Dec 2015
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Phase 3, randomised, triple-blind trial of cholecalciferol in restless legs syndrome (RLS), sponsored by King Abdulaziz University. Primary endpoint: International Restless Legs Scale at 12 weeks. Status: unknown.
02
Drugs
cholecalciferol
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT02256215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02256215.